Squarepoint
ANVS icon

Squarepoint’s Annovis Bio ANVS Stock Holding History

Squarepoint’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.3K Buy
+16,769
New +$27.3K ﹤0.01% 4332
2025
Q2 		– Sell
-12,574
Closed -$18.9K – 4457
2025
Q1 		$18.9K Buy
+12,574
New +$38.5K ﹤0.01% 4441

Other funds holding ANVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
SG
Sherry Group Mountain Home, Arkansas $107M AUM 11.17% 1-Year Est. Return
Wescott Financial Advisory Group
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.36B AUM 14.05% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Sterling Investment Advisors (Pennsylvania)
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $606M AUM 21.78% 1-Year Est. Return
Nicholson Wealth Management Group
Nicholson Wealth Management Group Charlestown, South Carolina $168M AUM 6.36% 1-Year Est. Return
Gill Capital Partners
Gill Capital Partners Denver, Colorado $366M AUM 12.21% 1-Year Est. Return
Robertson Stephens Wealth Management
Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return
RS
R Squared Central, Hong Kong $188M AUM 18.2% 1-Year Est. Return

Squarepoint's ANVS Position: Q3 2026 in Review

Squarepoint opened a new position in Annovis Bio (ANVS) in Q3 2026: 16,769 shares worth $21.3K. The stake represents ﹤0.01% of the portfolio and ranks #4332 among its holdings. This is a return to the name: Squarepoint previously reported a position in ANVS as recently as Q1 2025.

Squarepoint first reported a position in ANVS in Q1 2025 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold ANVS as of Q3 2026.

  • Squarepoint held 16,769 shares of Annovis Bio worth $21.3K as of Q3 2026.
  • Annovis Bio was a new Squarepoint position in Q3 2026.
  • Annovis Bio made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4332 holding.
  • Squarepoint first reported a position in Annovis Bio in Q1 2025 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.